Tuesday's edition of the Digital Daily includes a recap of the Presidential Address, in-depth coverage of the clinical trials session, highlights on what's happening today at the Annual Meeting and an all-new podcast on thoracic and lung cancer research.

#ASTRO19 Podcasts The ASTRO Annual Meeting podcasts feature attendees highlighting the most exciting and impactful work being presented in specific disease sites. For featured research in other disease sites, please consider attending the Science Highlights sessions.
Clinical Trials - Endometrial Patterns of Recurrence and Survival in the Randomized Portec-3 Trial of Chemoradiotherapy for High-Risk Endometrial Cancer
Clinical Trials - PBT versus IMRT in esophageal cancer Phase II Trial: Proton beam therapy offers lower toxicities without harming progression-free survival in patients with esophageal cancer versus intensity-modulated radiation therapy
Clinical Trials - Hodgkin Lymphoma PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 by the GHSG
Clinical Trials - Neuroblastoma Role of Radiotherapy Dose-Escalation for High-Risk Neuroblastoma with Post-Surgical Primary Site Gross Residual Disease: A Report from the COG ANBL0532 Study
Clinical Trials - ORIOLE Primary outcomes of a Phase II randomized trial of observation versus stereotactic ablative radiation for oligometastatic prostate cancer (ORIOLE)
Virtual Meeting Preview Want a sample of what’s happening at the 2019 ASTRO Annual Meeting in Chicago? Check out the virtual meeting preview.
Certificates Claim your continuing education credits or print your certificate of attendance for the 2019 Annual Meeting by Friday, October 18, 2019.